Back to Directory
Last Updated: 09/06/2026
Intract Pharma
Cambridge
Founded 2015
Oral delivery platform for biologics targeting inflammatory diseases
Intract Pharma is a biotechnology company developing proprietary formulation platforms for the oral delivery of complex biologics including monoclonal antibodies and proteins.
The technology enables precision delivery to the colon for local and systemic immunomodulation, targeting gastrointestinal and systemic immune-mediated inflammatory diseases.
The platform is available for licensing and underpins an internal pipeline of oral biologic therapies in preclinical and clinical development.